114 related articles for article (PubMed ID: 7713553)
1. Mycobacterial infection in guinea pigs.
Balasubramanian V; Wiegeshaus EH; Smith DW
Immunobiology; 1994 Oct; 191(4-5):395-401. PubMed ID: 7713553
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of tuberculosis: pathway to apical localization.
Balasubramanian V; Wiegeshaus EH; Taylor BT; Smith DW
Tuber Lung Dis; 1994 Jun; 75(3):168-78. PubMed ID: 7919306
[TBL] [Abstract][Full Text] [Related]
3. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
4. Vaccine-induced cytokine responses in a guinea pig model of pulmonary tuberculosis.
McMurray DN; Allen SS; Jeevan A; Lasco T; Cho H; Skwor T; Yamamoto T; McFarland C; Yoshimura T
Tuberculosis (Edinb); 2005; 85(5-6):295-301. PubMed ID: 16253558
[TBL] [Abstract][Full Text] [Related]
5. Progressive pulmonary tuberculosis is not due to increasing numbers of viable bacilli in rabbits, mice and guinea pigs, but is due to a continuous host response to mycobacterial products.
Dannenberg AM; Collins FM
Tuberculosis (Edinb); 2001; 81(3):229-42. PubMed ID: 11466035
[TBL] [Abstract][Full Text] [Related]
6. Tuberculosis: the return of an old enemy.
Collins FM
Crit Rev Microbiol; 1993; 19(1):1-16. PubMed ID: 8481210
[TBL] [Abstract][Full Text] [Related]
7. Animal models of tuberculosis.
Gupta UD; Katoch VM
Tuberculosis (Edinb); 2005; 85(5-6):277-93. PubMed ID: 16249122
[TBL] [Abstract][Full Text] [Related]
8. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
9. [Exogenous re-infection in tuberculosis].
Tsuchiya T
Kekkaku; 2006 Feb; 81(2):79-91. PubMed ID: 16529009
[TBL] [Abstract][Full Text] [Related]
10. [Studies on the virulence in the guinea pig of tuberculosis bacilli isolated from patients with pulmonary tuberculosis before treatment in Shanghai].
Yang DY
Zhonghua Jie He He Hu Xi Za Zhi; 1989 Feb; 12(1):15-7, 61. PubMed ID: 2500258
[TBL] [Abstract][Full Text] [Related]
11. Clinical strains of Mycobacterium tuberculosis display a wide range of virulence in guinea pigs.
Palanisamy GS; DuTeau N; Eisenach KD; Cave DM; Theus SA; Kreiswirth BN; Basaraba RJ; Orme IM
Tuberculosis (Edinb); 2009 May; 89(3):203-9. PubMed ID: 19251482
[TBL] [Abstract][Full Text] [Related]
12. Optimal models to evaluate the protective efficacy of tuberculosis vaccines.
Griffin JF; Chinn DN; Rodgers CR; Mackintosh CG
Tuberculosis (Edinb); 2001; 81(1-2):133-9. PubMed ID: 11463234
[TBL] [Abstract][Full Text] [Related]
13. Host-parasite relationships in experimental airborne tuberculosis. V. Lack of hematogenous dissemination of Mycobacterium tuberculosis to the lungs in animals vaccinated with Bacille Calmette-Guérin.
Fok JS; Ho RS; Arora PK; Harding GE; Smith DW
J Infect Dis; 1976 Feb; 133(2):137-44. PubMed ID: 812927
[TBL] [Abstract][Full Text] [Related]
14. Mycobacterium bovis BCG vaccination modulates TNF-alpha production after pulmonary challenge with virulent Mycobacterium tuberculosis in guinea pigs.
Yamamoto T; Lasco TM; Uchida K; Goto Y; Jeevan A; McFarland C; Ly L; Yamamoto S; McMurray DN
Tuberculosis (Edinb); 2007 Mar; 87(2):155-65. PubMed ID: 17289434
[TBL] [Abstract][Full Text] [Related]
15. [Protective efficacy of BCG Tokyo 172 in the guinea pig model of pulmonary tuberculosis].
Yamamoto T; Phalen S; Uchida K; Umemori K; Nojima Y; Horiuchi Y; Goto Y; McMurray DN; Yamamoto S
Kekkaku; 2000 May; 75(5):379-88. PubMed ID: 10853313
[TBL] [Abstract][Full Text] [Related]
16. Protective efficacy of recombinant (Ag85A) BCG Tokyo with Ag85A peptide boosting against Mycobacterium tuberculosis-infected guinea pigs in comparison with that of DNA vaccine encoding Ag85A.
Sugawara I; Udagawa T; Taniyama T
Tuberculosis (Edinb); 2007 Mar; 87(2):94-101. PubMed ID: 16815096
[TBL] [Abstract][Full Text] [Related]
17. Re-formulation of selected DNA vaccine candidates and their evaluation as protein vaccines using a guinea pig aerosol infection model of tuberculosis.
Vipond J; Clark SO; Hatch GJ; Vipond R; Marie Agger E; Tree JA; Williams A; Marsh PD
Tuberculosis (Edinb); 2006; 86(3-4):218-24. PubMed ID: 16520093
[TBL] [Abstract][Full Text] [Related]
18. Influence of BCG vaccination on the pathogenesis of experimental airborne tuberculosis.
Smith DW; Fok JS; Ho RS; Harding GE; Wiegeshaus E; Arora PK
J Hyg Epidemiol Microbiol Immunol; 1975; 19(4):407-17. PubMed ID: 812904
[No Abstract] [Full Text] [Related]
19. Determinants of vaccine-induced resistance in animal models of pulmonary tuberculosis.
McMurray DN
Scand J Infect Dis; 2001; 33(3):175-8. PubMed ID: 11303805
[TBL] [Abstract][Full Text] [Related]
20. Current status of TB vaccines.
Gupta UD; Katoch VM; McMurray DN
Vaccine; 2007 May; 25(19):3742-51. PubMed ID: 17321015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
